SCHEMBL9643191

SCHEMBL9643191

CC(C)(C)COC1=C(OCC(C)(C)C)C(=O)c2c(N)cccc2C1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.50
PTPRC P08575 1/20 0.46
NAT1 P18440 3/20 0.40
FGR P09769 1/20 0.38
PIM1 P11309 1/20 0.38
MAOA P21397 1/20 0.38
CSNK1A1 P48729 1/20 0.38
CSNK1D P48730 1/20 0.38
DYRK1A Q13627 1/20 0.38
HIPK2 Q9H2X6 1/20 0.38
CSNK1G1 Q9HCP0 1/20 0.38
RAB9A P51151 4/20 0.37
ATM Q13315 3/20 0.37
NPC1 O15118 3/20 0.37
MAPT P10636 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ALDH1A1 P00352 2/20 0.36
POLB P06746 2/20 0.36
MAPK1 P28482 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9641755 0.82 ADORA2A (0.55) ADORA2APTPRCNAT1FGRPIM1
SCHEMBL9643215 0.81 NSD2 (0.39)
SCHEMBL9642941 0.79 ALDH1A1 (0.50) PTPRCMAOARAB9AATMNPC1
SCHEMBL9643124 0.79 ADORA2A (0.51) ADORA2APTPRCFGRPIM1MAOA
SCHEMBL9642248 0.78 ADORA2A (0.50) ADORA2APTPRCFGRPIM1MAOA
SCHEMBL9642511 0.77 ADORA2A (0.49) ADORA2APTPRCFGRPIM1MAOA
SCHEMBL9643379 0.77 S100A4 (0.55) PTPRCNAT1RAB9ANPC1MAPT
SCHEMBL9641734 0.76 ADORA2A (0.60) ADORA2APTPRCFGRPIM1MAOA
SCHEMBL9642689 0.76 ADORA2A (0.47) ADORA2APTPRCRAB9AATMNPC1
SCHEMBL9641981 0.75 ADORA2A (0.50) ADORA2APTPRCFGRPIM1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0215622-B1 NAPHTHALENE ANTI-PSORIATIC AGENTS AND PROCESS FOR MAKING THEM SYNTEX (U.S.A.) INC. (US) 1992-06-17 EP disclosed
US-4946845-A STABLE ANTIINFLAMMATORY AGENTS, LIPOXYGENASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1990-08-07 US disclosed
EP-0146145-B1 NAPHTHALENE ANTI-PSORIATIC AGENTS SYNTEX (U.S.A.) INC. (US) 1989-08-30 EP disclosed
US-4792556-A LIPOXYGENASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1988-12-20 US disclosed
EP-0215622-A2 Naphthalene anti-psoriatic agents and process for making them SYNTEX (U.S.A.) INC. (US) 1987-03-25 EP disclosed
US-4593120-A Naphthalene-1,4-dicarboxylic acid group SYNTEX (U.S.A.) INC. (US) 1986-06-03 US disclosed
EP-0107512-B1 1,4-ACYLOXYNAPHTHALENE DERIVATIVES, TOPICAL COMPOSITIONS CONTAINING THEM, METHODS FOR THEIR PREPARATION, AND INTERMEDIATES THEREFOR SYNTEX (U.S.A.) INC. (US) 1986-02-26 EP disclosed
EP-0146145-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1985-06-26 EP disclosed
US-4466981-A Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1984-08-21 US disclosed
EP-0107512-A1 1,4-Acyloxynaphthalene derivatives, topical compositions containing them, methods for their preparation, and intermediates therefor SYNTEX (U.S.A.) INC. (US) 1984-05-02 EP disclosed
US-4442127-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1984-04-10 US disclosed